STOCK TITAN

Oscar Health Inc SEC Filings

OSCR NYSE

Welcome to our dedicated page for Oscar Health SEC filings (Ticker: OSCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Oscar Health’s filings can run hundreds of pages, packed with medical loss ratio math, state-by-state premium detail, and technology capitalization rules—enough to overwhelm even seasoned analysts. If you have ever asked, “How do I find Oscar Health’s quarterly earnings report 10-Q filing?” or searched for “Oscar Health insider trading Form 4 transactions,” you know the challenge.

Stock Titan solves it. Our AI reads every 10-K, 10-Q, 8-K, and proxy the moment they post to EDGAR, then delivers plain-English explanations. Want the cash-burn trend without scanning footnotes? Need Form 4 insider transactions real-time to see when executives buy shares? Curious about how Oscar’s telehealth investment shows up in the annual report 10-K simplified? One click, instant clarity.

Here is what you can track today:

  • Revenue and membership shifts in each Oscar Health SEC filings explained simply
  • Oscar Health executive stock transactions Form 4 with real-time alerts
  • Oscar Health proxy statement executive compensation breakdowns
  • Material policy updates via Oscar Health 8-K material events explained
  • Quarterly results through the Oscar Health earnings report filing analysis

Because filings update fast, our platform refreshes the moment a document hits EDGAR, ensuring you never miss an 8-K about a new state license or a Form 4 hinting at insider confidence. Understanding Oscar Health SEC documents with AI means spending minutes, not hours, to uncover the metrics that move premiums, profitability, and your investment decisions.

Rhea-AI Summary

Janet Liang, President of Oscar Insurance and a reporting person for Oscar Health, Inc. (OSCR), reported changes in her beneficial ownership on a Form 4. On 09/02/2025 she had 7,303 shares of Class A common stock disposed under transaction code F at a price of $16.66 per share; the filing explains these shares were withheld by the issuer to satisfy tax withholding arising from the vesting of restricted stock units (RSUs). After the reported transaction(s), Ms. Liang beneficially owns 179,865 shares of Class A common stock, which includes shares to be issued in connection with the vesting of one or more RSUs. The Form 4 is signed by an attorney-in-fact on 09/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Oscar Health insider reporting: Adam McAnaney, the companys Chief Legal Officer, disposed of 1,845 shares of Class A common stock on 09/02/2025 at a reported price of $16.66 per share. After the transaction, he beneficially owns 181,093 shares, which includes shares to be issued upon vesting of restricted stock units (RSUs). The filing states the 1,845 shares were withheld by the issuer to satisfy tax withholding obligations related to RSU vesting rather than an open-market sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Mario Schlosser, President of Technology & CTO and a director of Oscar Health, reported a routine insider disposition on 09/02/2025. The filing shows 23,879 shares of Class A common stock were disposed of under code F at a price of $16.66 per share; the explanation states these shares were withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs). After the transaction, Schlosser beneficially owns 501,148 shares, a figure that the filer says includes shares to be issued on RSU vesting. The form is signed by an attorney-in-fact on 09/04/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Oscar Health, Inc. (OSCR) filed a Form 8-K on 22 Jul 2025 to notify investors that it has issued a press release containing preliminary second-quarter 2025 results and a revised full-year 2025 outlook. The press release is furnished as Exhibit 99.1 and, per the filing, is not deemed “filed” under Exchange Act Section 18. No quantitative metrics, guidance figures, or additional material events are included in the body of the 8-K. Other than furnishing the exhibit, the company reported no changes to previously disclosed risk factors, transactions, or governance matters.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.93%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Oscar Health (OSCR)?

The current stock price of Oscar Health (OSCR) is $20.69 as of October 14, 2025.

What is the market cap of Oscar Health (OSCR)?

The market cap of Oscar Health (OSCR) is approximately 5.3B.
Oscar Health Inc

NYSE:OSCR

OSCR Rankings

OSCR Stock Data

5.27B
212.68M
4.03%
76.77%
19.19%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
NEW YORK